These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 6991798)
1. [Expectorant and liquescent preparations in the therapy of bronchial asthma and nonspecific lung diseases and their prevention]. Komarov FI; Daniliak IG; Guliaeva FE; Mindlina GI; Zhukova AV Klin Med (Mosk); 1980 Apr; 58(4):19-24. PubMed ID: 6991798 [No Abstract] [Full Text] [Related]
2. [The use of expectorant agents]. Galsanov Shch B Sov Med; 1987; (12):100-5. PubMed ID: 3328304 [No Abstract] [Full Text] [Related]
3. [Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug]. Fossati C Clin Ter; 1975 Jul; 74(1):63-82. PubMed ID: 770054 [No Abstract] [Full Text] [Related]
4. [Evaluation of a broncho-secretolytic in lung specialties with the help of a simple measuring method]. Wilde W Arztl Forsch; 1966 Mar; 20(3):149-56. PubMed ID: 6014420 [No Abstract] [Full Text] [Related]
6. [Experiences with the new mucolytic agent Bisolvon in general practice, with special reference to asthmoid states]. Stäubli C Praxis; 1966 Jul; 55(30):850-3. PubMed ID: 5953646 [No Abstract] [Full Text] [Related]
7. Drug effects on viscoelasticity of mucus. Puchelle E; Zahm JM; Polu JM; Sadoul P Eur J Respir Dis Suppl; 1980; 110():195-208. PubMed ID: 6938383 [No Abstract] [Full Text] [Related]
8. [The treatment of bronchial inflammatory diseases with a new drug association with mucolytic and expectorant activity]. Moncalvo F; Rossi A Clin Ter; 1971 Jul; 57(6):505-26. PubMed ID: 5136487 [No Abstract] [Full Text] [Related]
9. [Effects of different methods of drug administration on clinico-immunological indices and expectoration in patients with nonspecific lung diseases]. Provotorov VM; Pritsepov IuL Klin Med (Mosk); 1995; 73(2):63-4. PubMed ID: 7609431 [No Abstract] [Full Text] [Related]
10. Clinical experience with a new secretolytic drug. Villa R; Orlandini GC Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759 [No Abstract] [Full Text] [Related]
11. [Effects of various expectorants on sputum viscoelasticity in vivo (author's transl)]. Shimura S; Sato S; Aoki T; Takishima T Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Mar; 18(3):161-70. PubMed ID: 7392320 [No Abstract] [Full Text] [Related]
12. Evaluating the efficacy of mucoactive aerosol therapy. Fuloria M; Rubin BK Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385 [TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of bronchosecretolytic disorders]. Schmidt OP Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928 [No Abstract] [Full Text] [Related]
15. [Clinical study of the cough sedative, expectorant and eupneic properties of the preparation, "Cardiazol-Paracodin" Knoll]. Bini P; Romagnoli E Minerva Med; 1971 Feb; 62(17):837-41. PubMed ID: 5551772 [No Abstract] [Full Text] [Related]
20. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride]. Trombini V Minerva Med; 1969 Sep; 60(76):3600-3. PubMed ID: 5823757 [No Abstract] [Full Text] [Related] [Next] [New Search]